Protokinetix Inc (PKTX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Protokinetix Inc (PKTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7572
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ProtoKinetix Inc (ProtoKinetix) is a biotechnology company that develops solutions for cell survival and health. The company develops anti-aging glycopeptides used to protect cell lines including hela cells, neonatal fibroblasts, adult fibroblast, human neuronal stem cells, CD34+ cells and keratinocytes. It anti-aging glycopeptides also have commercial applications in the harvesting, storage, and transplantation of cells, tissues, and organs. ProtoKinetix offers products for health, stem cell and dermatology applications. It serves medical researchers in the areas of regenerative medicine and therapy for diseases. The company partners with universities and private research researchers to conduct its research activities. It performs tests in various outsourced laboratories to test neuronal retinal cells in living tissue for the treatment of macular degeneration. ProtoKinetix is headquartered in Marietta, Ohio, the US.

Protokinetix Inc (PKTX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Protokinetix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Protokinetix Inc, Medical Devices Deals, 2012 to YTD 2018 9
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Protokinetix Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
ProtoKinetix Acquires Certain Patents from University of Alberta 11
Partnerships 12
ProtoKinetix Enters into Research Agreement with University of British Columbia 12
ProtoKinetix and Proactive Immune Sciences Enter into Agreement 13
ProtoKinetix Enters into Research Agreement with University of British Columbia 14
ProtoKinetix Enters into Contract Research Agreement with ITR Labs 15
Equity Offering 16
Protokinetix Raises Additional USD0.4 Million in Private Placement of Shares 16
Protokinetix Raises USD0.2 Million in Private Placement of Shares 17
ProtoKinetix Raises USD0.2 Million in First Tranche of Private Placement of Shares 18
ProtoKinetix Raises USD0.2 Million in Private Placement of Units 19
ProtoKinetix Raises USD0.12 Million in Private Placement of Common Stock 20
Protokinetix Inc – Key Competitors 21
Protokinetix Inc – Key Employees 22
Protokinetix Inc – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Legal and Regulatory 24
Jan 17, 2017: ProtoKinetix Announces Investigator Sponsored Clinical Trial Submitted to Health Canada for the use of AAGP in the Treatment of Type 1 Diabetes 24
Product News 25
Aug 10, 2018: ProtoKinetix enters into 3rd phase of Retinal Cell Replacement Therapy Testing at UBC 25
May 24, 2017: Protokinetix Completes First Year Of Trials On Retinal Replacement Therapy Using Aagp 26
Mar 09, 2017: Protokinetix Announces Start Of Phase 1 & Phase 2 Clinical Trials For The Use Of AAGP PKX-001 Treated Islet Cells In The Treatment Of Type 1 Diabetes 27
Jan 24, 2017: ProtoKinetix Announces Investigator Sponsored Human Clinical Trial Application Using AAGP Has Been Approved by Health Canada 28
Other Significant Developments 29
Nov 16, 2017: The Effects of ProtoKinetix’ Anti-Aging Glycopeptide (AAGP) on Immune Cell Banking and Functions Relevant to Immunotherapy 29
Oct 17, 2017: Scientific Update for Diabetes, Kidney Ischemia, Liver Perfusion, Retinal Cell Replacement, Monoclonal Antibody Production and Immune Cell Cryopreservation Recovery 30
Feb 07, 2017: ProtoKinetix Updates Testing Progress on Neuronal Retinal Cells in Living Tissue for the Treatment of Macular Degeneration 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Protokinetix Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Protokinetix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Protokinetix Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Protokinetix Inc, Medical Devices Deals, 2012 to YTD 2018 9
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ProtoKinetix Acquires Certain Patents from University of Alberta 11
ProtoKinetix Enters into Research Agreement with University of British Columbia 12
ProtoKinetix and Proactive Immune Sciences Enter into Agreement 13
ProtoKinetix Enters into Research Agreement with University of British Columbia 14
ProtoKinetix Enters into Contract Research Agreement with ITR Labs 15
Protokinetix Raises Additional USD0.4 Million in Private Placement of Shares 16
Protokinetix Raises USD0.2 Million in Private Placement of Shares 17
ProtoKinetix Raises USD0.2 Million in First Tranche of Private Placement of Shares 18
ProtoKinetix Raises USD0.2 Million in Private Placement of Units 19
ProtoKinetix Raises USD0.12 Million in Private Placement of Common Stock 20
Protokinetix Inc, Key Competitors 21
Protokinetix Inc, Key Employees 22

List of Figures
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Protokinetix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Protokinetix Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Protokinetix Inc (PKTX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Azimut Exploration Inc (AZM):企業の財務・戦略的SWOT分析
    Summary Azimut Exploration Inc (AEI) is a mining company that offers exploration and development of mineral resources. The company carries out the business of acquisition, exploration, and development of gold, copper, silver, chromium, uranium and rare earth element properties. It also offers projec …
  • Allscripts Healthcare Solutions, Inc.:企業の戦略・SWOT・財務分析
    Allscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Allscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Cochlear Ltd (COH):医療機器:M&Aディール及び事業提携情報
    Summary Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions. It develops, manufactures and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage. Its major products include c …
  • NovoCure Ltd (NVCR):企業の製品パイプライン分析
    Summary NovoCure Ltd (NovoCure) develops and commercializes novel delivery systems for the treatment of cancers of brain, abdomen, and torso. Its proprietary Tumor Treating Fields (TTF) technology platform uses electric fields tuned to specific frequencies for disrupting the division solid tumor can …
  • Koninklijke Ahold Delhaize N.V.:戦略・SWOT・企業財務分析
    Koninklijke Ahold Delhaize N.V. - Strategy, SWOT and Corporate Finance Report Summary Koninklijke Ahold Delhaize N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Marubeni Corporation:企業の戦略・SWOT・財務情報
    Marubeni Corporation - Strategy, SWOT and Corporate Finance Report Summary Marubeni Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Entravision Communications Corporation (EVC):企業の財務・戦略的SWOT分析
    Entravision Communications Corporation (EVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • SYNNEX Corp (SNX):企業の財務・戦略的SWOT分析
    SYNNEX Corp (SNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • AiCuris GmbH & Co KG:製薬・医療:M&Aディール及び事業提携情報
    Summary AiCuris GmbH & Co KG (AiCuris) a subsidiary of Santo Holding AG is a drug development company that discovers and develops antibacterial and antiviral agents for the treatment of life-threatening infectious diseases. The company’s pipeline products include antiviral and antibacterial agents f …
  • Crrc Corporation Limited:企業の戦略・SWOT・財務分析
    Crrc Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Crrc Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Titan Company Ltd (TITAN):企業の財務・戦略的SWOT分析
    Summary Titan Company Ltd (Titan) is a retailing company. Its product portfolio includes eyewear, watches and accessories; jewelry; and fashion accessories. The company offers jewelry products comprising of pendant, chain, gold coin, earrings, finger ring and neckwear. Titan offers eyewear products …
  • The Israel Electric Corporation Ltd:企業の戦略的SWOT分析
    The Israel Electric Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Alitair Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Alitair Pharmaceuticals Inc (Alitair) is a pharmaceutical company that provides orphan drugs and medicine products. The company provides orphan drug products and RX and OTC cough and cold products. It offers orphan drug products such as ALT and oral drugs that are widely used to treat variou …
  • McWane Inc:企業の戦略的SWOT分析
    McWane Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • REV Group Inc (REVG):企業の財務・戦略的SWOT分析
    REV Group Inc (REVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fujifilm SonoSite Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fujifilm SonoSite Inc (Fujifilm SonoSite), a subsidiary of Fujifilm Holdings Corp, is a medical device company. It designs and develops ultrasound systems for use in a variety of medical specialties including anesthesiology, cardiology, critical care, endocrinology, orthopedic surgery, radio …
  • Abbott Diabetes Care Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abbott Diabetes Care Inc (ADC), formerly TheraSense Inc, a subsidiary of Abbott Laboratories, is a medical device company that discovers, develops, manufactures, and markets pharmaceuticals and medical products for personal use and hospital use. The company’s products include glucose monitor …
  • AVEO Pharmaceuticals Inc (AVEO):製薬・医療:M&Aディール及び事業提携情報
    Summary AVEO Pharmaceuticals Inc (AVEO) is a biopharmaceutical company which focuses on the discovery, development and commercialization of drugs for the treatment of various types of cancers. Its proprietary platform delivers insights into cancer and related diseases. AVEO develops its lead candida …
  • Activision Blizzard, Inc.:企業の戦略・SWOT・財務分析
    Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report Summary Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nautilus Minerals Inc.:企業のM&A・事業提携・投資動向
    Nautilus Minerals Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nautilus Minerals Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆